Sanofi Dives Back Into ADCs With Seagen Pact
Deal Value Under Wraps
Despite underwhelming sales for some cancer products and problems within the pipeline, Sanofi is forging ahead with an agreement for up to three ADCs with Seagen.

Despite underwhelming sales for some cancer products and problems within the pipeline, Sanofi is forging ahead with an agreement for up to three ADCs with Seagen.